Trusted Resources: Evidence & Education
Scientific literature and patient education texts
source: Columbia Surgery
Graves’ disease is an autoimmune disorder that affects the thyroid gland, the butterfly-shaped gland located in the lower front of the neck. Graves’ disease causes the thyroid gland to produce excess amounts of thyroid hormone (hyperthyroidism).
Symptoms of Graves’ Disease:
Graves’ disease can cause eye and skin changes. Such symptoms may occur before or after a person is diagnosed with Graves’ disease. In many cases, these symptoms resolve with treatment.
Eye symptoms associated with Graves’ disease may include:
• Swelling around the eyes
• Bulging eyes/ inflammation
• Rarely, diminished or double vision
Most Graves’ disease-related eye problems (called Graves’ ophthalmopathy) are mild and are not permanent. They are more frequent and serious among patients who smoke, however.
Horizon Pharma plc Announces Phase 3 Confirmatory Trial Evaluating Teprotumumab (OPTIC) for the Treatment of Active ...Horizon Pharma plc today announced topli...
Mycophenolate Plus Methylprednisolone Versus Methylprednisolone Alone in Active, Moderate-to-Severe Graves’ Or...Background: European guidelines recomme...
The History of Levothyroxine – The Most Prescribed Drug in the United States With Dr. James V. Hennessey from Harv...In this interview, Dr. Hennessey describ...
Preoperative Clinical Features of Reactivated of Graves’ Orbitopathy After Orbital DecompressionPurpose: To investigate the incidence a...
FDA Committee Unanimously Recommends Approval of Teprotumumab for Thyroid Eye DiseaseThe Dermatologic and Ophthalmic Drugs Ad...
Noel Rose, MD, PhD (Deceased)Dr. Rose was associated with Johns Hopki...
Disease Presentation and Remission Rate in Graves’ Disease Treated With Antithyroid Drugs: Is Gender Really a ...Objective: Male gender is considered an...
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.